Bvf Inc Sutro Biopharma, Inc. Transaction History

Bvf Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $541,000 - $808,000	-100,000 Reduced 2.9%	3,347,946 $27.1 Million
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $19.6 Million - $38.6 Million	2,522,798 Added 272.69%	3,447,946 $28.3 Million
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $1.4 Million - $2.31 Million	98,323 Added 11.89%	925,148 $13.8 Million
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $20.8 Million - $28.3 Million	-1,027,337 Reduced 55.41%	826,825 $18.8 Million
Q4 2020 Feb 12, 2021	SELL	$10.16 - $23.98 $12.5 Million - $29.6 Million	-1,233,033 Reduced 39.94%	1,854,162 $40.3 Million
Q3 2020 Nov 13, 2020	BUY	$7.44 - $13.15 $5.35 Million - $9.45 Million	718,803 Added 30.35%	3,087,195 $31 Million
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $13.7 Million - $20.9 Million	1,892,910 Added 398.1%	2,368,392 $18.4 Million
Q1 2020 May 15, 2020	BUY	$6.19 - $12.16 $806,470 - $1.58 Million	130,286 Added 37.74%	475,482 $4.85 Million
Q4 2019 Feb 14, 2020	BUY	$8.15 - $11.39 $8,150 - $11,390	1,000 Added 0.29%	345,196 $3.8 Million
Q3 2019 Nov 14, 2019	BUY	$7.91 - $11.76 $2.72 Million - $4.05 Million	344,196 New	344,196 $3.13 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $105M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.